Autor: |
Variath C; Lawrence S Bloomberg School of Nursing, Joint Centre for Bioethics, University of Toronto, Toronto, Canada., Climans SA; Departments of Neurology and Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Canada., Edelstein K; Department of Psychiatry, University of Toronto, Toronto, Canada.; Department of Supportive Care, Princess Margaret Cancer Centre, Toronto, Canada., Bell JAH; Department of Psychiatry, University of Toronto, Toronto, Canada.; Department of Supportive Care, Princess Margaret Cancer Centre, Toronto, Canada.; Dalla Lana School of Public Health, Joint Centre for Bioethics, University of Toronto, Toronto, Canada. |
Abstrakt: |
In most jurisdictions where medical assistance in dying (MAiD) is legal, patients must have decision-making capacity. Brain cancer often damages the cognitive networks required to maintain decision-making capacity. Using qualitative methodology guided by a relational ethics conceptual framework, this study explored neuro-oncology clinicians' perspectives on access to and eligibility for MAiD for patients diagnosed with brain cancer. We interviewed 24 neuro-oncology clinicians from 6 countries. Participants described the unique challenges facing brain cancer patients, potentially resulting in their inequitable access to MAiD. The findings highlight the importance of early end-of-life conversations, advance care planning, and access to end-of-life treatment options. |